GAITHERSBURG, MD, UNITED STATES, December 2, 2024 /EINPresswire / -- OpenDNA , a leading provider of advanced genetic testing solutions, today anno ...

Key Takeaways A Phase 2 study of Amgen's experimental weight-loss treatment didn't meet expectations of analysts.Concerns ...

France was the only country to see its obesity rates fall during this time, the data has demonstrated. Nepal, Bangladesh and ...

Nov. 20, 2024 — Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function ...

States with the lowest number of high school and college graduates also have the highest percentage of obese citizens. This ...

A phase 3 trial of Biohaven’s taldefgrobep alfa in spinal muscular atrophy (SMA) has missed its primary endpoint. The biotech ...

To assess the potential of targeting NK2R for the treatment of obesity, the researchers first administered the natural ligand for NK2R, neurokinin A, to obese mice. This led to substantial weight ...